PlainRecalls
FDA Drug Moderate Class II Ongoing

Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120. NDC: 29033-056-01

Reported: February 10, 2021 Initiated: January 25, 2021 #D-0249-2021

Product Description

Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120. NDC: 29033-056-01

Reason for Recall

CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.

Details

Recalling Firm
Nostrum Laboratories Inc
Units Affected
7071 bottles
Distribution
Nationwide
Location
Kansas City, MO

Frequently Asked Questions

What product was recalled?
Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120. NDC: 29033-056-01. Recalled by Nostrum Laboratories Inc. Units affected: 7071 bottles.
Why was this product recalled?
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 10, 2021. Severity: Moderate. Recall number: D-0249-2021.